Makale detayı · 2021
Serum zonulin and claudin-5 levels in patients with schizophrenia
YÖKSİS
OpenAlex
SJR Q1
JCR Q1
Atıf 68
Üst %10
Yüzdelik 92.3%
FWCI 3.11
- Yıl
- 2021
- Tür
- article
Veri kaynağı ayrımı
- YÖKSİS YÖKSİS makale kaydı
- YÖKSİS dergi adı EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Katalog eşleşmesi (ISSN) European Archives of Psychiatry and Clinical Neuroscience
- OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)
Özet
Özet henüz derlenmedi; DergiPark / OpenAlex kuyruğu işlenince burada görünecek.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
68 atıf
OpenAlex cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 40 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- Serum zonulin and claudin-5 levels in children with attention-deficit/hyperactivity disorder 2021
- Serum zonulin and claudin-5 levels in children with attention-deficit/hyperactivity disorder 2021
- Evaluation of Serum Zonulin and Occludin Levels in Bipolar Disorder 2023
- Serum claudin-5, claudin-11, occludin, vinculin, paxillin, and beta-catenin levels in preschool children with autism spectrum disorder 2023
- Serum claudin-5, claudin-11, occludin, vinculin, paxillin, and beta-catenin levels in preschool children with autism spectrum disorder 2023
- Serum claudin-5, claudin-11, occludin, vinculin, paxillin, and beta-catenin levels in preschool children with autism spectrum disorder 2023
- Investigation of the Relation between Epithelial Barrier Function and Autism Symptom Severity in Children with Autism Spectrum Disorder 2022
- Investigation of the Relation between Epithelial Barrier Function and Autism Symptom Severity in Children with Autism Spectrum Disorder 2022
- Correlates of Zonulin and Claudin-5, markers of intestinal and brain endothelial permeability, in Parkinsons Disease: A pilot study 2023
- Correlates of Zonulin and Claudin-5, markers of intestinal and brain endothelial permeability, in Parkinsons Disease: A pilot study 2023